Association between cholesterol and liver injury risk in solid cancer patients treated with PD-1 inhibitors: evidence from two cohort studies

Abstract Background To assess the association between baseline serum lipids and the risk of severe hepatic immune-related adverse events (irAEs) in solid cancer patients treated with PD-1 inhibitors. Methods This retrospective study included a discovery cohort (N = 601) and an independent high-risk...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Jing Lei, Yi Wang, Zhiping Jin, Guoyou Qin, Tianshu Liu, Ningping Zhang, Minzhi Lv
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2026-02-01
סדרה:	BMC Cancer
נושאים:	Immune checkpoint inhibitor Hepatic immune-related adverse events Lipid metabolism Total cholesterol Low-density lipoprotein cholesterol.
גישה מקוונת:	https://doi.org/10.1186/s12885-026-15801-0
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!